Jpmorgan Chase & Co »

Neurobo Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Neurobo Pharmaceuticals (NRBO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Neurobo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Neurobo Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurobo Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $22 7 3.14
2024-06-30 $24 5 4.80
2024-03-31 $33 8 4.13

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Neurobo Pharmaceuticals

Armistice Capital
Affinity Asset Advisors
Vanguard Group
Geode Capital Management
Ferguson Wellman Capital Management
State Street Corporation
Northern Trust
BlackRock
BlackRock
Tower Research Capital
Bank of America Corporation
Morgan Stanley
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Neurobo Pharmaceuticals